Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind placebo-controlled trial

Copolymer 1 Multiple Sclerosis Study Group

Research output: Contribution to journalArticlepeer-review

1830 Scopus citations

Fingerprint

Dive into the research topics of 'Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences